Growing Cancer Research, Personalized Medicine Sectors to Drive Molecular Cytogenetics Market

QYResearchReports.com announces the addition of a new report to its growing market intelligence repository. The new report comprises a key addition to the database of QYResearchReports.com on the biotechnology and pharmaceuticals sector and delivers a detailed profile of the global molecular cytogenetics market.


Brooklyn, NY -- (SBWIRE) -- 09/27/2017 -- The report, titled 'Global Molecular Cytogenetics Market Size, Status and Forecast 2022,' provides a detailed look at the development trajectory exhibited by the global molecular cytogenetics market from 2012 to 2017 and further elaborates on the market's growth potential from 2017 to 2022.

Get free sample copy of the report at: https://www.qyresearchreports.com/sample/sample.php?rep_id=1302998&type=E

Molecular cytogenetics is a research technique that allows scientists to take a closer look at the makeup of individual parts of genomes. This has become a vital tool in the treatment sector of several diseases whose genetic makeup is essential in how they manifest and how they can be cured. The detailed information provided by molecular cytogenetics allows researchers to develop targeted treatments, which is likely to drive demand for continued development of the molecular cytogenetics sector in the coming years.

The application of molecular cytogenetics in the development of cancer therapeutics is likely to remain vital for the global molecular cytogenetics market in the coming years. Cancer has become a global health concern in recent years, with several types of cancer emerging as a growing threat across the world. The development of cancer is closely linked with the genetic makeup of tumors, which has led to growing resource allocation to understanding the genomic background of cancers. The problems posed by the heterogeneity of metastatic tumors has led to growing use of genetic material to study and treat the cancer, which is likely to further drive the adoption of molecular cytogenetics in cancer research.

To check avail discount on this report, visit at: https://www.qyresearchreports.com/sample/sample.php?rep_id=1302998&type=D

Other key application sectors of the molecular cytogenetics market include personalized medicine, genetic disorders, and others such as cardiovascular and infectious diseases. Personalized medicine is also likely to contribute significantly to the global molecular cytogenetics market in the coming years, aided by the steady development of the Human Genome Project and the increasing understanding being acquired about the way human genomes manifest and affect disease progression in individuals. The booming pharmaceutical industry in developed countries is likely to drive the demand from the molecular cytogenetics market in the development of personalized medicine in the coming years.

The growing prevalence of neurological diseases could also emerge as a significant factor for the global molecular cytogenetics market in the coming years. Like cancer, neurological diseases are intimately linked with the genetic makeup of an individual and can be affected by various cytogenetic factors, making molecular cytogenetics a vital factor.

By type, the molecular cytogenetics market is segmented into fluorescence in-situ hybridization (FISH), which is likely to remain the dominant test type in the molecular cytogenetics market, and array-comparative genomic hybridization (aCGH).

Geographically, the report covers the performance of the molecular cytogenetics market in the U.S., the EU, Southeast Asia, India, China, and Japan. Developed countries such as the U.S. and the U.K. are likely to remain the leading contributors to the global molecular cytogenetics market in the coming years due to the widespread availability of advanced medical research infrastructure and easy incorporation of technological advances into the healthcare sector.

Key companies operating in the molecular cytogenetics market include SciGene Corporation, Abbott Laboratories, Danaher Corporation, F. Hoffman-La Roche Ltd., Bio-Rad Laboratories, Affymetrix Inc., Oxford Gene Technology, Applied Spectral Imaging, Thermo Fisher Scientific Inc., Leica Biosystems, Illumina Inc., and Life Technologies Corporation.

About QYReseachReports.com
QYReseachReports.com delivers the latest strategic market intelligence to build a successful business footprint in China. Our syndicated and customized research reports provide companies with vital background information of the market and in-depth analysis on the Chinese trade and investment framework, which directly affects their business operations. Reports from QYReseachReports.com feature valuable recommendations on how to navigate in the extremely unpredictable yet highly attractive Chinese market.

Contact US:
Brooklyn, NY 11230
United States
Toll Free: 866-997-4948 (USA-CANADA)
Tel: +1-518-618-1030
Email: sales@qyresearchreports.com